Both of the upregulation of miR-766-5p and the downregulation of CDKN1A was proved to reverse the CML inhibition mediated by NEAT1 [180]. The gene discussed is CDKN1A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.